Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Zanger

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Clinical Pharmacology and Therapeutics|October 12, 2020
Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41Ulrich M Zanger, Kyoko Momoi, Ute Hofmann, et al.
Human Mutation|August 19, 2006
Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme functionElke Schaeffeler, Michel Eichelbaum, Walter Reinisch, et al.
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2015
Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9Jessica K Rieger, Sandra Reutter, Ute Hofmann, et al.
Proteomics|April 30, 2009
Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liverElmar Langenfeld, Ulrich M Zanger, Klaus Jung, et al.
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Epigenetics and MicroRNAs in PharmacogeneticsUlrich M Zanger, Kathrin Klein, Nicole Kugler, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Epigenetics & Chromatin|April 23, 2015
Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintainedGoran Kungulovski, Suneetha Nunna, Maria Thomas, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|October 12, 2020
Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41Ulrich M Zanger, Kyoko Momoi, Ute Hofmann, et al.
Human Mutation|August 19, 2006
Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme functionElke Schaeffeler, Michel Eichelbaum, Walter Reinisch, et al.
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2015
Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9Jessica K Rieger, Sandra Reutter, Ute Hofmann, et al.
Proteomics|April 30, 2009
Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liverElmar Langenfeld, Ulrich M Zanger, Klaus Jung, et al.
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Epigenetics and MicroRNAs in PharmacogeneticsUlrich M Zanger, Kathrin Klein, Nicole Kugler, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Epigenetics & Chromatin|April 23, 2015
Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintainedGoran Kungulovski, Suneetha Nunna, Maria Thomas, et al.
Pageof 14